Study: Anti-psychotics raise mortality in older Alzheimer's patients

01/8/2009 | Google

U.K. researchers found that 46% of Alzheimer's patients who were treated with psychiatric drugs, including Risperdal and Thorazine, were alive after two years, compared with 71% of those who took placebo. The study was conducted from 2001 to 2004 among 165 patients ages 67 to 100 with moderate to severe forms of the disease. The findings underscore the need for personalized drug therapies, an Alzheimer's specialist said.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX